Ad is loading...
GFVCX
Price
$17.06
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VFINX
Price
$549.92
Change
+$3.00 (+0.55%)
Updated
Nov 21 closing price
Ad is loading...

GFVCX vs VFINX

Header iconGFVCX vs VFINX Comparison
Open Charts GFVCX vs VFINXBanner chart's image
Goldman Sachs Focused Value C
Price$17.06
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$549.92
Change+$3.00 (+0.55%)
VolumeN/A
CapitalizationN/A
GFVCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFVCX vs. VFINX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVCX is a StrongBuy and VFINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. GFVCX (58.5M). VFINX pays higher dividends than GFVCX: VFINX (1.24) vs GFVCX (0.00). GFVCX was incepted earlier than VFINX: GFVCX (9 years) vs VFINX (48 years). GFVCX is a more actively managed with annual turnover of: 82.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than GFVCX: VFINX (0) vs GFVCX (1000). VFINX (30.57) and GFVCX (30.22) have marching annual gain over last year. VFINX return over 5 years is better than : 91.24 vs. GFVCX (49.40).
GFVCXVFINXGFVCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years48 years-
Gain YTD21.24925.01185%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets58.5M1.28T0%
Annual Yield % from dividends0.001.24-
Returns for 1 year30.2230.5799%
Returns for 3 years13.1427.0749%
Returns for 5 years49.4091.2454%
Returns for 10 yearsN/A189.02-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS8.130.28
+3.57%
iTeos Therapeutics
CNC60.351.25
+2.12%
Centene Corp
SKY100.081.94
+1.98%
Champion Homes Inc
CNNE20.770.23
+1.12%
Cannae Holdings
CLDI2.15-0.14
-6.11%
Calidi Biotherapeutics